Loading organizations...
Gray's Creek Capital Partners operates as an institutional family office, meticulously managing a long-only investment portfolio. The firm employs a bottoms-up fundamental process, strategically deploying capital across diversified public equities. Primary focus areas include healthcare and technology, seeking opportunities to generate significant returns and maximize both yield and growth for entrusted assets.
The firm was established in 2013 by co-founders and managing partners Jason Little and Gerrit Parker Jr. Their foundational insight stemmed from a desire to apply a rigorous, research-driven investment philosophy within a dedicated family office structure. Little and Parker Jr. leveraged their collective experience to create a platform emphasizing diligent capital allocation and long-term value creation.
Serving the capital preservation and growth needs of its institutional family, Gray's Creek Capital Partners operates as a specialized investment vehicle. Its mission centers on maximizing yield and growth opportunities exclusively within public equity markets. They maintain a forward-looking perspective, adapting strategies to navigate evolving market conditions while adhering to core investment tenets.
Gray's Creek Capital Partners has 3 tracked investments across 3 companies. The latest tracked deal is $5.5M Seed in Gardenuity in October 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 19, 2023 | Gardenuity | $5.5M Seed | Alan Shor, Michael Mann | ANN Berry, JON Ledecky, RAJ Shah, RAM Velidi, Ross Jones, Deason Capital Services, JFO Group, North Texas Angel Network, Revtech Ventures |
| Sep 1, 2021 | LEXEO Therapeutics | $100.0M Series B | Daniel Saul Sundheim, JOY Ghosh | Omega Funds, Alexandria Venture Investments, CAM Capital, Invus, Janus Henderson Investors, Laurion Capital Management, Longitude Capital, Lundbeckfond Ventures, PBM Capital, Verition Fund Management, Woodline Partners |
| Aug 5, 2021 | Pepgen | $112.5M Other Equity | — | Adage Capital Management, Cureduchenne Ventures, Deerfield Management, Laurion Capital Management, Alexis Dormandy, Joshua Resnick, Samsara BioCapital, Tudor Ventures, Viking Global Investors |